Hyperpolarized [1-13C]pyruvate
Sponsors
Aarhus University, Aarhus Universitet, Region Midtjylland, Rigshospitalet
Conditions
ALS (Amyotrophic Lateral Sclerosis)Autosomal Dominant Polycystic kidney disease (ADPKD)Breast cancerDiabetic Kidney DiseaseHeart failureOvarian cancerPancreatic CancerPrimary liver cancer
Phase 1
Phase 2
IMPROCAS - Improved Prediction of Ovarian Cancer Surgery
RecruitingCTIS2023-503398-39-00
Start: 2024-03-01Target: 40Updated: 2025-05-30
QUANTITATIVE RENAL HYPERPOLARIZED [1-13C]PYRUVATE PERFUSION AND METABOLIC IMAGING IN DIABETIC KIDNEY DISEASE
RecruitingCTIS2023-508824-36-00
Start: 2024-09-24Target: 27Updated: 2025-02-12
Chronic kidney disease – imaging the metabolic derangements with ultra-sensitive MRI
RecruitingCTIS2024-512491-35-00
Start: 2024-04-01Target: 30Updated: 2024-12-20
MRI with hyperpolarized pyruvate in gliblastoma - a phase II study
RecruitingCTIS2024-515408-37-00
Start: 2020-04-01Target: 10Updated: 2025-11-28
Early detection of hepatocellular carcinoma by Hyperpolarized [1-
13C]pyruvate MRI
RecruitingCTIS2024-512490-27-00
Start: 2023-06-19Target: 46Updated: 2024-07-25
Phase IIa Clinical Trial: Feasibility Study on Non-Invasive Simultaneous Hyperpolarized [1-13C]Pyruvate Magnetic Resonance Spectroscopy and 18F-FDG PET (hyperPET) for Metabolic Imaging in Patients with Cancer
RecruitingCTIS2024-516131-28-00
Start: 2022-04-18Target: 15Updated: 2024-08-28
MRI of Neurometabolic Impairment in ALS and TIA Using Hyperpolarized Pyruvate
RecruitingCTIS2024-516954-24-00
Start: 2020-05-01Target: 46Updated: 2025-01-17
MR-HYPERPOLARISATION SCANNING WITH HYPERPOLARISED PYRUVATE (13C) IN PANCREATIC CANCER PATIENTS – A FEASIBILITY STUDY
RecruitingCTIS2024-517358-86-00
Start: 2024-09-13Target: 16Updated: 2025-09-25